Nomura Asset Management CO LTD Editas Medicine, Inc. Transaction History

Nomura Asset Management CO LTD

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$9.99 - $21.35 $0 - $0	0 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$14.08 - $27.63 $0 - $0	0 New	0 $0
Q4 2021 Feb 01, 2022	BUY	$26.55 - $40.57 $0 - $0	0 New	0 $0
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $0 - $0	0 New	0 $0
Q2 2021 Aug 06, 2021	BUY	$31.29 - $56.64 $0 - $0	0 New	0 $0
Q1 2021 May 14, 2021	BUY	$39.71 - $90.58 $0 - $0	0 New	0 $0
Q4 2020 Feb 12, 2021	BUY	$27.07 - $84.35 $0 - $0	0 New	0 $0
Q3 2020 Nov 12, 2020	BUY	$28.06 - $37.16 $0 - $0	0 New	0 $0
Q2 2020 Aug 13, 2020	BUY	$18.5 - $34.34 $0 - $0	0 New	0 $0
Q1 2020 May 14, 2020	BUY	$14.88 - $32.78 $0 - $0	0 New	0 $0
Q4 2019 Feb 13, 2020	BUY	$19.49 - $32.63 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$22.49 - $26.81 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$20.48 - $27.76 $0 - $0	0 New	0 $0
Q1 2019 May 10, 2019	BUY	$19.43 - $26.41 $0 - $0	0 New	0 $0
Q1 2019 May 10, 2019	BUY	$19.43 - $26.41 $0 - $0	0 New	0 $0
Q4 2018 Feb 12, 2019	SELL	$18.19 - $31.79 $149,158 - $260,678	-8,200 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$29.84 - $44.08 $244,688 - $361,456	8,200 New	8,200 $272,000

247

57M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $168M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

Stay updated on Nomura Asset Management CO LTD with notifications on news.